July 2, 2025
The University of Cincinnati's Natalie Kreitzer, MD, was featured in an Emergency Medicine News article discussing new practices to optimize emergency care for patients with traumatic brain injuries.
July 1, 2025
In a moment of pride for Greater Cincinnati and the national blood banking community, Hoxworth Blood Center, University of Cincinnati, has been honored with the 2025 Association of Donor Relations Professionals Media Partner of the Year Award in partnership with Local 12 (WKRC-TV) and health reporter Liz Bonis.
July 1, 2025
The University of Cincinnati's chapter of Remote Area Medical, in collaboration with Anthem Blue Cross and Blue Shield, will host a free clinic at St. Xavier High School on July 19-20.
July 1, 2025
The University of Cincinnati's Robert Cohen, MD, commented to MedCentral on two new studies presented at the American Diabetes Association’s (ADA) 85th Scientific Sessions in Chicago.
Discover public health careers, salaries and degree paths. Explore jobs in epidemiology, health education, global health and more at UC.
June 27, 2025
The University of Cincinnati's Robert Cohen, MD, spoke with Everyday Health to discuss new research that suggests diet soda drinkers with type 2 diabetes may have more success losing weight and achieving diabetes remission if they switch to water.
June 25, 2025
Hoxworth Blood Center, the University of Cincinnati and the Cincinnati Reds are teaming up for summer blood donations, offering an exclusive Reds Ringer T-shirt for blood donors in July and several ways to earn free Reds tickets.
June 24, 2025
UC President Neville Pinto shares letter related to the future of DEI at UC.
June 24, 2025
A study co-authored by Rose Marie Ward, PhD, a UC psychology researcher, uncovers the complexity of disordered eating in young adults. The study appears in the Journal of Eating Disorders.
June 23, 2025
The University of Cincinnati Cancer Center, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Jabez Biosciences are partnering to open a new phase 1 clinical trial studying JBZ-001, a potential new treatment for acute myeloid leukemia, funded by a National Cancer Institute grant.